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Netherlands Society of Cardiology/Holland Heart House, Utrecht, The Netherlands and to mainly focus on original and review articles. At that time, the first Editorial Comment in April 2001 ended with the phrase 'We hope that you really appreciate our efforts to make the Netherlands Heart Journal a new platform for cardiovascular research in a broadest sense of the word'! [2] . Our aims at that time were 1) to reach PubMed to become internationally recognised, and 2) to be listed by the Web of Science (WOS), including the Science Citation Index (SCI), in order to obtain an impact factor [3, 4] .
Let us briefly go over the main events and achievements of NHJ since 2001. On 1 January 2005, our journal changed its publishing company from Mediselect BV to Bohn, Stafleu & van Loghum (BSL, Houten, the Netherlands), which over time became a division of the Springer Verlag Concern, Germany.
In 2006, NHJ was adopted by PubMed Central (www. pubmedcentral.gov) [4, 5] , which is a free full-text archive of biomedical and life sciences journal literature at the US National Institutes of Health's National Library of Medicine (NIH/NLM). In 2007, NHJ was internationally recognised by PubMed, the most important literature database comprising more than 26 million citations for biomedical literature from MEDLINE, life science journals, and online books (www.pubmed.gov). PubMed has now retroactively listed all NHJ articles (almost 2000!) from its very start in April 2001. In 2008, NHJ was indexed by WOS and received its first impact factor in 2009, which was 1.392 at that time and by 2015 it had increased to 2.062 [6] [7] [8] [9] [10] [11] .
These major achievements were not given to us for free. It has cost much effort and many years for NHJ to enter the international arena. Once getting there, we have had to battle to stay there and it requires an ongoing fighting spirit to preserve and, more importantly, to improve the scientific level of our journal. This achievement has been made possible, and continues to be possible, through the cooperation and support of many institutions and individuals. In particular the Publisher (predominantly represented by Lieda Meester) together with my former Chief Editors, Professors de Boer, Doevendans, Wilde and Zijlstra, laid the basis for these martial accomplishments. Furthermore, over the years we have received support from the NVVC [12, 13] , the Cardiovascular Institute for Education (CVOI) [14] , the Interuniversity Cardiology Institute of the Netherlands (ICIN) [15] , and the Netherlands Heart Foundation (NHS). Lastly, the true scientific level of a journal is determined by the members of the Editorial Board, in particular the Deputy and the Associate Editors, and of course the reviewers. I fully acknowledge their support for NHJ and for me over the years. In my turn, I sincerely hope I served you well during this 30-year period from 1987-2017.
'Great is the art of beginning, but greater is the art of ending' the American poet Henry Wadsworth Longfellow (1807-1882) once said. A new editorial period will begin and I am fully confident that NHJ will continue to thrive. In the style of Ernest Hemingway, I say farewell to arms with one of his quotes; 'it is now hard to leave the country but it is in no way impossible' [1] .
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